XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Note 13 - Segment Information
6 Months Ended
Jul. 01, 2023
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

13.    Segment Information

 

The Company follows ASC 280, “Segment Reporting,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note 1 to the Company’s Consolidated Financial Statements included in its Annual Report on Form 10-K for the year ended December 31, 2022).

 

Segment operating income includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments. The following tables reflect the results of the reportable segments consistent with the Company’s management system:

 

Thirteen Weeks Ended

July 1, 2023

 

Specialty

Health Care

  

Engineering

  

Life Sciences

and IT

  

Corporate

  

Total

 

Revenue

 $35,528  $21,014  $10,493  $-  $67,035 

Cost of services

  25,727   16,192   6,356   -   48,275 

Gross profit

  9,801   4,822   4,137   -   18,760 

Selling, general and administrative

  6,043   4,380   2,300   -   12,723 

Depreciation and amortization of

property and equipment

  92   116   34   -   242 

Amortization of acquired

intangible assets

  -   -   46   -   46 

Operating income

 $3,666  $326  $1,757  $-  $5,749 

Total assets as of July 1, 2023

 $39,961  $42,668  $17,947  $4,961  $105,537 

Property and equipment acquired

 $29  $190  $2  $7  $228 

 

 

 

Thirteen Weeks Ended

July 2, 2022

 

Specialty

Health Care

  

Engineering

  

Life Sciences

and IT

  

Corporate

  

Total

 

Revenue

 $43,457  $20,906  $9,983  $-  $74,346 

Cost of services

  30,575   15,395   6,693   -   52,663 

Gross profit

  12,882   5,511   3,290   -   21,683 

Selling, general and administrative

  7,179   4,107   1,978   -   13,264 

Depreciation and amortization of

property and equipment

  97   103   25   -   225 

Operating income

 $5,606  $1,300  $1,288   -  $8,194 

Total assets as of July 2, 2022

 $29,889  $29,523  $7,962  $5,051  $72,425 

Property and equipment acquired

 $21  $124  $43  $4  $192 

 

 

 

Twenty-Six Weeks Ended

July 1, 2023

 

Specialty

Health Care

  

Engineering

  

Life Sciences and IT

  

Corporate

  

Total

 

Revenue

 $74,658  $39,504  $19,997  $-  $134,159 

Cost of services

  53,185   30,365   12,555   -   96,375 

Gross profit

  21,473   8,869   7,442   -   37,784 

Selling, general and administrative

  13,241   8,298   4,580   -   26,119 

Depreciation and amortization of

property and equipment

  199   244   70   -   513 

Amortization of acquired

intangible assets

  -   -   91   -   91 

Gain on sale of assets

  -   (395

)

  -   -   (395

)

Operating income

 $8,033  $722  $2,701  $-  $11,456 

Total assets as of July 1, 2023

 $39,961  $42,668  $17,947  $4,961  $105,537 

Property and equipment acquired

 $47  $478  $19  $15  $559 

 

 

 

Twenty-Six Weeks Ended

July 2, 2022

 

Specialty

Health Care

  

Engineering

  

Life Sciences and IT

  

Corporate

  

Total

 

Revenue

 $95,641  $40,804  $19,862  $-  $156,307 

Cost of services

  67,758   30,059   13,387   -   111,204 

Gross profit

  27,883   10,745   6,475   -   45,103 

Selling, general and administrative

  15,149   8,219   4,043   -   27,411 

Depreciation and amortization of

property and equipment

  217   199   47   -   463 

Operating income

 $12,517  $2,327  $2,385  $-  $17,229 

Total assets as of July 2, 2022

 $29,889  $29,523  $7,962  $5,051  $72,425 

Property and equipment acquired

 $48  $289  $63  $9  $409 

 

 

The Company derives a majority of its revenue from offices in the United States. Revenues reported for each operating segment are all from external customers. The Company is domiciled in the United States and its segments operate in the United States, Canada, Puerto Rico and Europe. Revenue by geographic area for the thirteen and twenty-six weeks ended July 1, 2023 and July 2, 2022 was as follows:

 

  

Thirteen Weeks Ended

  

Twenty-Six Weeks Ended

 
  

July 1, 2023

  

July 2, 2022

  

July 1, 2023

  

July 2, 2022

 

Revenue

                

United States

 $62,797  $71,189  $126,120  $149,982 

Canada

  1,832   1,235   3,413   2,464 

Puerto Rico

  1,540   1,279   3,102   2,499 

Europe

  866   643   1,524   1,362 
  $67,035  $74,346  $134,159  $156,307 

 

Total assets by geographic area as of the reported periods were as follows:

 

  

July 1,

2023

  

December 31,

2022

 

Total assets

        

United States

 $97,247  $81,558 

Canada

  2,037   1,640 

Puerto Rico

  2,346   1,401 

Europe

  3,907   3,365 
  $105,537  $87,964